A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer

Abstract

Background: Optimal chemotherapy (CT) for advanced breast treatment should be effective, well tolerated and convenient. In this study the efficacy and safety of the fully oral combination of oral vinorelbine (Navelbine Oral) plus capecitabine (Xeloda) in metastatic breast cancer (MBC) patients pretreated with anthracycline, was evaluated.

Conclusion: Oral vinorelbine-capecitabine shows very promising activity and low toxicity in MBC treatment, with high compliance of the patients.

Keywords

• chemotherapyve
• MBC
• combination
• 1ST-LINE
• efficacy